 NEW YORK, NY, March 10, 2022 GLOBE NEWSWIRE -- Enzo Biochem, Inc. NYSE: ENZ, a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Markets Life Sciences MedTech Investor Forum, Tuesday, March 22, 2022 at 3:00pm Eastern Time. The format will be a fireside chat discussion hosted by KeyBancs Research Analyst Paul Knight. 